Hong Li

Title: Innovations and Contributions of Inventor Hong Li

Introduction

Hong Li is an accomplished inventor based in Cranbury, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and fusion proteins. With a total of 2 patents, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

One of Hong Li's latest patents is titled "Antibody and use thereof." This patent describes an anti-CLDN18.2 antibody or an antigen-binding fragment that exhibits high specificity and affinity to CLDN18.2. The antibody can effectively bind to CLDN18.2 and mediate the killing of cells expressing this target. Additionally, the patent includes a pharmaceutical composition comprising the antibody, which can be utilized in the preparation of drugs for the prevention and treatment of tumors. Another notable patent is "Fusion proteins and methods of use." This patent details compositions that include a fusion protein comprising flagellin and at least one antigen. The fusion protein activates Toll-like Receptor 5, and methods for stimulating a protective immune response are also outlined.

Career Highlights

Throughout his career, Hong Li has worked with various organizations, including Vaxinnate Corporation and Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. His experience in these companies has allowed him to refine his expertise in biotechnology and contribute to innovative solutions in the field.

Collaborations

Hong Li has collaborated with notable colleagues, including Langzhou Song and Ge Liu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

In summary, Hong Li is a prominent inventor whose work in biotechnology has led to significant advancements in antibody and fusion protein development. His contributions have the potential to enhance therapeutic strategies for treating various diseases.